Data Analytics report
LIMEN Step 4: Inputs Closed, Device Still Open
A founder brief on what Step 4 established, what remains unknown, and the next valid research work.
Executive Summary
- Step 4Source: LIMEN Step 4 Integrator acceptance index is complete at the input-record level. Science, Product, Legal, Business, and Backend overlays passed fresh Independent QA and Integrator acceptance.
- The concept is clearer, but no device exists. The accepted records define evidence boundaries, failure routing, governance, research prioritization, and abstract Backend constraints. They do not select a technology or authorize implementation.
- The next useful work is narrower, not more universal. Choose one bounded problem and comparator, then make the unselected R0 software decisions and promote reference vectors before any software-only implementation.
- Project status stays REVISION. Release, publication, deployment, fabrication, biological work, animal work, human work, and product development remain unauthorized.
Exact accepted lane packages, QA evidence, Integrator acceptance, and report-shaping notes.
Documentation closure did not create an implementation
Five lane-owned input overlays are accepted. No architecture, Backend technology choice, reference-vector set, R0 runtime, physical bench, biological interface, or device is accepted or implemented. The bars show exact record counts, not percent complete.
Exact accepted lane packages, QA evidence, Integrator acceptance, and report-shaping notes.
Exact counts transcribed from the accepted Step 4 records indexed in SOURCE_NOTES.md.
| Layer | Count | Meaning |
|---|---|---|
| Accepted lane input overlays | 5 | Science, Product, Legal, Business, and Backend exact records |
| Selected Backend technology choices | 0 | All ten remain unselected |
| Promoted reference-vector sets | 0 | R0-PROM-001 remains open |
| Implemented R0 runtimes | 0 | No implementation exists |
| Accepted physical devices | 0 | No bench or biological device is accepted |
What Step 4 actually closed
Each lane closed one class of research input. Acceptance is limited to the exact records below; it does not transfer authority across lanes.
Accepted Step 4 input records
Five lane-owned overlays; acceptance closes documentation and semantics only.
Exact lane closure rows derived from the accepted records indexed in SOURCE_NOTES.md.
| Lane | What closed | Still open |
|---|---|---|
| Backend | Semantic-input blockers and abstract decision constraints | All ten technology choices, reference-vector promotion, runtime, implementation |
| Business | Problem/population routing and comparator bookkeeping | No branch selected; LIM-X-GAP-001 remains open or blocked |
| Legal / ethics | Research-only governance map and neutral A/B/C option boundaries | Classification, approval, ethics authorization, regulatory path, FTO |
| Product | Deterministic state, guard, provenance, recovery, and calibration semantics | Architecture, biological values, parts, implementation, physical design |
| Science | Evidence lineage, route boundaries, prospective comparator rule | Chronic exact-route stability, selectivity, encoding, reversibility, advantage |
The concept is now controlled, not build-ready
The accepted record describes a two-way information question with explicit invalid states:
Peripheral source → observation candidate → provenance and artifact gate → bounded classification → computation → return request → authorization or inhibition → acknowledgement.
A command is not proof of delivery; a classifier output is not a neural fact; common infrastructure is not a universal biological map.
Exact accepted lane packages, QA evidence, Integrator acceptance, and report-shaping notes.
What the accepted record means
Plain-language interpretation of the accepted evidence and contracts.
Plain-language synthesis of the accepted Science, Product, Legal, Business, and Backend records.
| Area | Now controlled | Not proven |
|---|---|---|
| Architecture | Electronic, biohybrid, and combined families remain comparable research options | Selection, feasibility, superiority, safety, or build readiness of any family |
| Common platform | Schemas, provenance, uncertainty, calibration lifecycle, inhibition, and audit can be common | A universal biological map across nerves, people, species, or applications |
| Execution | Invalid identity, provenance, artifact, or permission must inhibit consequential output | A working state machine, runtime, hardware controller, or safe implementation |
| Human evidence | Short bounded direct nerve recording and stimulation have occurred in the same participants | Chronic fully implanted exact-route operation or pure direct-ENG-only closed loop |
The next valid work is a bounded R0 decision sequence
Do not jump from documentation closure to a device blueprint. The next actions must preserve the research-only boundary and remain reversible.
Next dependency-ordered actions
Research and software-only gates before any reconsideration of physical work.
Integrator dependency sequence derived from the accepted Step 4 blockers and exclusions.
| Step | Action | Acceptance condition |
|---|---|---|
| 1Source: Dependency-ordered LIMEN next actions | Freeze one bounded problem, population, function, endpoint, and lower-burden comparator | Science plus Legal/Ethics accept the boundary; no universality claim |
| 2Source: Dependency-ordered LIMEN next actions | Resolve the ten Backend R0 technology decisions without importing device assumptions | Owner-correct decision record passes fresh QA and Integrator review |
| 3Source: Dependency-ordered LIMEN next actions | Create and Science-accept exact synthetic reference vectors | R0-PROM-001 closes; provenance and failure cases reproduce |
| 4Source: Dependency-ordered LIMEN next actions | Implement and test the software-only R0 simulator | No hardware or biology; deterministic fail-closed behavior passes independent QA |
| 5Source: Dependency-ordered LIMEN next actions | Reconsider a non-biological R1 bench only after R0 evidence | Fresh owner packages, comparator rationale, and explicit authorization; rejected R1_BENCH_V1 is not reused |
Questions that still decide the direction
- Which single problem and population justify continued research?
- Which lower-burden external or temporary comparator sets the baseline?
- Can a decision-relevant direct nerve signal remain attributable and stable long enough for that bounded use?
- Can stimulation artifact, biological drift, and source substitution be detected before consequential output?
- Does any invasive branch offer a material advantage that survives safety, reversibility, maintenance, ethics, and regulatory burden?
- Which exact R0 reference vectors can Science accept before Backend implementation begins?
Exact accepted lane packages, QA evidence, Integrator acceptance, and report-shaping notes.
Caveats and assumptions
The human evidence remains bounded and short-term for the exact direct-nerve two-way route. Chronic direct recording plus stimulation in one fully implanted human platform remains open. Broad novelty, universality, feasibility, safety, efficacy, patentability, FTO, readiness, and availability are not established. R1_BENCH_V1 remains rejected and unaccepted.
Exact accepted lane packages, QA evidence, Integrator acceptance, and report-shaping notes.
Sources
- LIMEN Step 4 Integrator acceptance index
Exact accepted lane packages, QA evidence, Integrator acceptance, and report-shaping notes.